References
- Cines DB, Blanchette VS. Immune thrombocytopenic purpura. N Engl J Med. 2002;346:995–1008. doi: 10.1056/NEJMra010501
- Zhu F, Qiao J, Cao J, et al. Decreased level of cytotoxic T lymphocyte antigen-4 (CTLA-4) in patients with acute immune thrombocytopenia (ITP). Thromb Res. 2015;136:797–802. doi: 10.1016/j.thromres.2015.07.017
- Taaning E, Petersen S. Pattern of platelet-associated immunoglobulin (classes and IgG subclasses) in childhood immune thrombocytopenic purpura. Eur J Haematol. 1988;41:449–453. doi: 10.1111/j.1600-0609.1988.tb00226.x
- Audia S, Samson M, Mahevas M, et al. Preferential splenic CD8(+) T-cell activation in rituximab-nonresponder patients with immune thrombocytopenia. Blood. 2013;122:2477–2486. doi: 10.1182/blood-2013-03-491415
- Semple JW, Provan D. The immunopathogenesis of immune thrombocytopenia: T cells still take center-stage. Curr Opin Hematol. 2012;19:357–362. doi: 10.1097/MOH.0b013e3283567541
- Ji X, Zhang L, Peng J, et al. T cell immune abnormalities in immune thrombocytopenia. J Hematol Oncol. 2014;7:72. doi: 10.1186/s13045-014-0072-6
- Olsson B, Andersson PO, Jernas M, et al. T-cell-mediated cytotoxicity toward platelets in chronic idiopathic thrombocytopenic purpura. Nat Med. 2003;9:1123–1124. doi: 10.1038/nm921
- Zufferey A, Kapur R, Semple JW. Pathogenesis and therapeutic mechanisms in immune thrombocytopenia (ITP). J Clin Med. 2017;6. doi: 10.3390/jcm6020016
- McKenzie CG, Guo L, Freedman J, et al. Cellular immune dysfunction in immune thrombocytopenia (ITP). Br J Haematol. 2013;163:10–23. doi: 10.1111/bjh.12480
- Teft WA, Kirchhof MG, Madrenas J. A molecular perspective of CTLA-4 function. Annu Rev Immunol. 2006;24:65–97. doi: 10.1146/annurev.immunol.24.021605.090535
- Liu MF, Wang CR, Chen PC, et al. Increased expression of soluble cytotoxic T-lymphocyte-associated antigen-4 molecule in patients with systemic lupus erythematosus. Scand J Immunol. 2003;57:568–572. doi: 10.1046/j.1365-3083.2003.01232.x
- Lei C, Dongqing Z, Yeqing S, et al. Association of the CTLA-4 gene with rheumatoid arthritis in Chinese Han population. Eur J Hum Genet. 2005;13:823–828. doi: 10.1038/sj.ejhg.5201423
- Peng J, Liu C, Liu D, et al. Effects of B7-blocking agent and/or CsA on induction of platelet-specific T-cell anergy in chronic autoimmune thrombocytopenic purpura. Blood. 2003;101:2721–2726. doi: 10.1182/blood-2002-06-1666
- Li H, Ge J, Zhao H, et al. Association of cytotoxic T-lymphocyte antigen 4 gene polymorphisms with idiopathic thrombocytopenic purpura in a Chinese population. Platelets. 2011;22:39–44. doi: 10.3109/09537104.2010.521601
- Radwan ER, Goda RL. Lack of impact of cytotoxic T-lymphocyte antigen 4 gene exon 1 polymorphism on susceptibility to or clinical course of Egyptian childhood immune thrombocytopenic purpura. Clin Appl Thromb Hemost. 2015;21:378–382. doi: 10.1177/1076029613502254
- Jiang SY, Li LL, Yue J, et al. The effects of SP110's associated genes on fresh cavitary pulmonary tuberculosis in Han Chinese population. Clin Exp Med. 2016;16:219–225. doi: 10.1007/s10238-015-0339-4
- Cai L, Deng SL, Liang L, et al. Identification of genetic associations of SP110/MYBBP1A/RELA with pulmonary tuberculosis in the Chinese Han population. Hum Genet. 2013;132:265–273. doi: 10.1007/s00439-012-1244-5
- Guo L, Kapur R, Aslam R, et al. CD20+ B-cell depletion therapy suppresses murine CD8+ T-cell-mediated immune thrombocytopenia. Blood. 2016;127:735–738. doi: 10.1182/blood-2015-06-655126
- Oaks MK, Hallett KM. Cutting edge: a soluble form of CTLA-4 in patients with autoimmune thyroid disease. J Immunol. 2000;164:5015–5018. doi: 10.4049/jimmunol.164.10.5015
- Tivol EA, Borriello F, Schweitzer AN, et al. Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity. 1995;3:541–547. doi: 10.1016/1074-7613(95)90125-6
- Colucci F, Bergman ML, Penha-Goncalves C, et al. Apoptosis resistance of nonobese diabetic peripheral lymphocytes linked to the Idd5 diabetes susceptibility region. Proc Natl Acad Sci U S A. 1997;94:8670–8674. doi: 10.1073/pnas.94.16.8670
- Kasamatsu T, Ino R, Takahashi N, et al. PDCD1 and CTLA4 polymorphisms affect the susceptibility to, and clinical features of, chronic immune thrombocytopenia. Br J Haematol. 2018;180:705–714. doi: 10.1111/bjh.15085
- Sandler SG. The spleen and splenectomy in immune (idiopathic) thrombocytopenic purpura. Semin Hematol. 2000;37:10–12. doi: 10.1016/S0037-1963(00)90112-4
- Zhang J, Zhang Q, Li Y, et al. Immune dysregulation in primary immune thrombocytopenia patients. Hematology. 2018;23:1–7. doi: 10.1080/10245332.2017.1333294